Diabetes and cancer frequently coexist in the same subject, often with relevant clinical effects on the management and prognosis of the oncologic patient. However, existing guidelines do not deal with many clinical issues in this setting appropriately. Albeit collaboration between Diabetologists and Oncologists should play an important role in achieving appropriate levels of care, a high level of coordination or agreement between these specialists is seldom offered. There is an urgent need of a greater interdisciplinary integration between all specialists involved in this setting, to reach a shared approach ensuring that a compartmentalized organization is overcome. To this end the Italian Associations of Medical Diabetologists (AMD) and of Clinical Oncologists (AIOM) have created the Working Group "Diabetes and cancer". The working group, together with other experts from the Group "Diabetes Inpatient" by AMD, has prepared a diagnostic and therapeutic clinical pathway for the hospitalized oncological patient with diabetes. Herein we describe some suggested measures to assess, monitor and improve glycemic control within the hospital environment, integrating different specialists from both areas, as well as discharge planning specific for diabetes.
Profilo di cura del paziente oncologico ricoverato in ospedale
Gennaro Clemente;
2018
Abstract
Diabetes and cancer frequently coexist in the same subject, often with relevant clinical effects on the management and prognosis of the oncologic patient. However, existing guidelines do not deal with many clinical issues in this setting appropriately. Albeit collaboration between Diabetologists and Oncologists should play an important role in achieving appropriate levels of care, a high level of coordination or agreement between these specialists is seldom offered. There is an urgent need of a greater interdisciplinary integration between all specialists involved in this setting, to reach a shared approach ensuring that a compartmentalized organization is overcome. To this end the Italian Associations of Medical Diabetologists (AMD) and of Clinical Oncologists (AIOM) have created the Working Group "Diabetes and cancer". The working group, together with other experts from the Group "Diabetes Inpatient" by AMD, has prepared a diagnostic and therapeutic clinical pathway for the hospitalized oncological patient with diabetes. Herein we describe some suggested measures to assess, monitor and improve glycemic control within the hospital environment, integrating different specialists from both areas, as well as discharge planning specific for diabetes.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.